Mounjaro manufacturer makes $1 million in profit every 25 minutes
📈 Eli Lilly generates approximately $1 million in profit every 25 minutes according to a new BestBrokers report.
💰 The company achieved a net profit per employee of $412,264 in 2025.
🏆 Eli Lilly has overtaken Novo Nordisk as the leading global weight-loss drug manufacturer.
📊 Johnson & Johnson ranks first with a profit generation rate of $1 million every 19 minutes.
🌍 The top five pharma companies collectively generated over $99 billion in net profit over the last 12 months.
🇺🇸 Ten of the 16 analyzed pharmaceutical companies are based in the United States.
🔬 BestBrokers analysts highlight the industry's shift toward AI and next-generation therapies as key growth drivers.
Bullish Signals
- Eli Lilly is generating $1 million in profit every 25 minutes, demonstrating extraordinary earning power.
- The company achieved a net profit per employee of $412,264 in 2025, ranking second among major pharma firms for profit speed.
- Eli Lilly has successfully overtaken Novo Nordisk to become the leading weight-loss drug manufacturer globally.
- The top five pharmaceutical companies analyzed collectively generated more than $99 billion in net profit recently.
Full Analysis
A comprehensive forensic report by BestBrokers reveals that Eli Lilly, the manufacturer of Mounjaro, generates approximately $1 million in profit every 25 minutes. The analysis covers the top 200 public companies by market capitalization and highlights Eli Lilly's exceptional financial performance over the last 12 months.
Eli Lilly recorded a net profit per employee of $412,264 in 2025, ranking second among 16 major pharmaceutical companies for the speed of profit generation. The report notes that Eli Lilly has surpassed Novo Nordisk to become the leading weight-loss drug manufacturer globally.
The top five earners in the study—Johnson & Johnson, Eli Lilly, Merck, Roche, and Novo Nordisk—collectively generated over $99 billion in net profit recently. Alan Goldberg of BestBrokers attributes this success to transformative trends like weight-loss drugs and AI in medicine, positioning these firms as key players reshaping global healthcare.